Description
GLP-2 TZ
Dual GIP and GLP-1 Receptor Agonist
GLP-2 TZ is a synthetic peptide-based compound studied for its activity at glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. Its dual-receptor mechanism has made it a significant subject of scientific research into metabolic regulation, glucose homeostasis, and energy balance.
Research Overview
GLP-2 TZ has been investigated for its effects on incretin receptor signaling, glucose-dependent insulin secretion, and gastrointestinal processes involved in metabolic regulation. Research has also examined its influence on appetite-related signaling and body-weight regulation in clinical settings.
Compound Information
- Classification: Dual GIP/GLP-1 receptor agonist
- Research focus: Incretin signaling and metabolic physiology
- Intended designation: Research Use Only (RUO)
Third Party COA
Lab: SideChain Analytics
Date: October 21, 2026
Purity: 99.8%
Mass: 16.25 MG
This compound is available exclusively for in vitro laboratory research and scientific study conducted within Canada. It is not a drug, natural health product, or food product as defined under the Food and Drugs Act (R.S.C., 1985, c. F-27). It is not approved for human consumption, veterinary use, or any diagnostic or therapeutic application. This product has not been evaluated by Health Canada. Researchers are responsible for compliance with all applicable federal, provincial, and local regulations.





Reviews
There are no reviews yet.